Skip to main content
OpenTrials

Clinical trial condition

Spasm

Explore clinical trials studying Spasm. Study availability and eligibility vary by location and protocol.

84 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Spasm trial results

Completed

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm

NCT04671082

Conditions
Acute Pain, Back Muscle Spasm, Back Pain, +10 more
Locations
  • Clinical Research Institute of Arizona, LLC Surprise, Arizona, United States
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Alliance Research Institute Canoga Park, California, United States
  • Long Beach Clinical Trials Services, Inc Long Beach, California, United States
View all 56 locations
View Trial Details
Completed

Tolperisone in Acute Muscle Spasm of the Back

NCT03802565

Conditions
Acute Pain, Back Pain, Back Spasm Upper Back, +13 more
Locations
  • Tennessee Valley Pain Consultants Huntsville, Alabama, United States
  • Fiel Family and Sports Medicine Tempe, Arizona, United States
  • Center of Applied Research Little Rock, Arkansas, United States
  • Research Center of Fresno Fresno, California, United States
View all 43 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT03327402

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Preferred Research Partners Little Rock, Arkansas, United States
  • Clinical Neuroscience Solutions Inc Orlando, Florida, United States
  • Qualmedica Research, LLC Evansville, Indiana, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Completed

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT03260205

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex, Inc Dothan, Alabama, United States
  • Preferred Research Partners, Inc Little Rock, Arkansas, United States
  • CMB Clinical Trials Colton, California, United States
  • Sun Valley Research Center Imperial, California, United States
View all 48 locations
View Trial Details
Completed

Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years

NCT03325881

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • PEWMD, PA, ARCSM, PLLC, PRP, Inc. Little Rock, Arkansas, United States
  • Advanced Research Center Anaheim, California, United States
  • Riverside Medical Clinic Riverside, California, United States
View all 41 locations
View Trial Details

Related conditions